CAS: 66532-85-2; 4-Acetamidophenyl Diethylglycinate

该化合物是一种合成止痛剂和抗热剂,经常用作杀丙胺醇(乙氨基苯)的配方,其特点是能够减轻疼痛和减少发烧,在临床环境中成为常见的选择.Propacetamol通常通过静脉注射进行,允许迅速行动,特别是在口服不可行的情况下,特别有利于行动.该物质为溶解水,便于静脉注射使用.在使用时,propacetamol在体内代谢后产生杀螨醇,主要通过抑制丙基胺醇在中央...

结构式图片

上下游产品

CAS号17321-63-0 氯乙酸-4-乙酰氨基苯酯 | CAS号2644-21-5 ethyl 2-(diethy... | CAS号24376-01-0 2-(二乙基氨基)乙酸盐酸盐

合成工艺路线路线简述

    氯乙酸-4-乙酰氨基苯酯 以 二乙胺 作为反应溶剂,化学反应生成 丙帕他莫
    参考文献:P-Acetamidophenyl Diethylaminoacetate
    标题:P-Acetamidophenyl Diethylaminoacetate
    摘要:一种p-乙酰氨基酚衍生物,可溶于水并形成稳定的水溶液.该衍生物是p-乙酰氨基苯基二乙氨基乙酸盐,可选用非毒性药用可接受酸盐形式,特别是盐酸盐.该衍生物能够快速在生物体内释放对位乙酰氨基酚.

    海关参考信息

    专利信息


    专利号:US-2024287041-A1
    优先权日:2021-05-20
    标题 :Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
    发明人:BALOGLU ERKAN; AUSTAD BRIAN C; ROE DAVID G; KEDUC ANDREW; GOTTSCHLING STEPHEN EDMUND; HECKER EVAN
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The present invention relates to a method of preparing a compound represented by structural formula (VII), comprising reacting a compound represented by structural formula (II), with a compound represented by structural formula (III), in a solvent, in the presence of a Pd catalyst and one or more inorganic bases under conditions suitable to prepare a compound represented by structural formula (VII): The values and example values of the variables in structural formulas (VII), (II), and (III) are defined herein. The present invention also relates to crystalline Forms I and II of the compound represented by Structural Formula (VII), the use of the crystalline Forms in treating disease or disorders associated with CRM1 and method of preparing the crystalline Forms.

    专利号:AU-2022276509-A1
    优先权日:2021-05-20
    标题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    专利号:US-9994558-B2
    优先权日:2013-09-20
    标题 :Multicyclic compounds and methods of using same
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM; MCCAULEY DILARA; LANDESMAN YOSEF; GOLAN GALI; KALID ORI; SHECHTER SHARON
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to compounds represented by Structural Formula I: or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of structural formula I, or a pharmaceutically acceptable salt or composition thereof, e.g., in treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders (e.g., PAK-mediated, for example, PAK4-mediated, diseases and disorders).

    专利号:WO-2022246227-A1
    优先权日:2021-05-20
    标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms

    专利号:US-10363247-B2
    优先权日:2015-08-18
    标 题:(S,E)-3-(6-aminopyridin-3-yl)-N-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer
    发明人:BALOGLU ERKAN; SHACHAM SHARON; SENAPEDIS WILLIAM
    权利人:KARYOPHARM THERAPEUTICS INC
    摘要:The invention generally relates to substituted benzofuranyl compounds and, more particularly, to a compound represented by Structural Formula 1a: (I) or a pharmaceutically acceptable salt thereof. The invention also includes the synthesis and use of the compound of Structural Formula 1a, or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of diseases or disorder selected from cancer (e.g., lymphoma, such as mantle cell lymphoma), a neurodegenerative disease, an inflammatory diseases or an immune system disease (e.g., a T-Cell mediated autoimmune disease) in a subject in need thereof. The method comprises administering to a subject in need thereof a therapeutically effective amount of a compound of the invention, or a pharmaceutically acceptable salt thereof, or a composition comprising a compound of the invention, or a pharmaceutically acceptable salt thereof.

    专利号:CA-3219525-A1
    优先权日:2021-05-20
    标 题:Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms
    重庆赛维药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.succeway.com
    电话: 86-23-68624447👤
    📞重庆赛维药业有限公司 ⚠️参考联系方式

    销售电话:86-23-68624447
    邮箱:bgs@succeway.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Oscier, Bosley and Milner. (2007). Update in Anaesthesia.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知